Treatment of thrombus formation associated with the MicroMed DeBakey VAD using recombinant tissue plasminogen activator

Circulation

Volumn 106, Issue 13 SUPPL., 2002, Pages

  Rothenburger, Markus ^a   Wilhelm, Markus J ^a   Hammel, Dieter ^a   Schmidt, Christoph ^a   Tjan, Tonny D T ^a   Böcker, Dirk ^a   Scheld, Hans H ^a   Schmid, Christof ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

MicroMed DeBakey LVAD; Recombinant tissue plasminogen activator (rt PA); Thrombolytic therapy; Thrombus formation

Indexed keywords

ALTEPLASE; UROKINASE;

ADULT; ANTICOAGULATION; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; FEMALE; FIBRINOLYTIC THERAPY; HEART ASSIST DEVICE; HEART CATHETERIZATION; HUMAN; IMPELLER; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PULSATILE FLOW; PUMP; THROMBOEMBOLISM; THROMBOGENESIS;

ADOLESCENT; ADULT; CORONARY THROMBOSIS; FEMALE; FIBRINOLYTIC AGENTS; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 0037167679     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Vetter HO, Kaulbach HG, Schmitz C, et al. Experience with the Novacor left ventricular assist system as a bridge to cardiac transplantation including the new wearable system. J Thorac Cardiovasc Surg. 1995;109:74-80.
2. McCarthy PM, Smedira NO, Vargo RL, et al. One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technology. J Thorac Cardiovasc Surg. 1998;115:904-912.
3. Schmid C, Weyand M, Nabavi DG, et al. Cerebral and systemic embolization during left ventricular support with the Novacor N100 device. Ann Thorac Surg. 1998:65:1703-1710.
4. Himmelreich G, Ullmann H, Riess H, et al. Pathophysiologic role of contact activation in bleeding followed by thromboembolic complications after implantation of a ventricular assist device. ASAIO J. 1995;41:M790-M794.
5. Noon GP, Morley DL. Irwin S. et al. Clinical experience with the MicroMed DeBakey ventricular assist device. Ann Thorac Surg. 2001; 71:S133-S138.
6. Wieselthaler GM. Schima H, Lassnigg AM, et al. Lessons learned from the first clinical implants of the DeBakey ventricular assist device axial pump: a single center report. Ann Thorac Surg. 2001;71:S139-S143.
7. Scheld HH, Hammel D, Schmid C, et al. Beating herat implantation of a wearable NOVACOR left-ventricular asssist device. Thorac Cardiovasc Surg. 1996;44:62-66.
8. Chalela JA, Katzan I, Liebeskind DS, et al. Safety of intra-arterial thrombolysis in the postoperative period. Stroke. 2001;32:1365-1369.
9. Chartier L, Bera J, Delmonez M, et al. Free-floating thrombi in the right heart. Diagnosis, management, and prognostic indexes in 38 consecutive patients. Circulation. 1999;99:2779-2783.
10. Rester BT, Warnock JL. Patel PB, et al. Lysis of a left ventricular thrombus with recombinant tissue plaminogen activator. Chest. 2001;120:681-683.
11. The GUSTO Angiographic Investigators. The comparative effects of tissue plasminogen activator, streptokinase, or both on coronary patency, ventricular function and survival after myocardial infarction. N Engl J Med. 1993;329:1615-1622.
12. Kasirajan V, Smedira NG, Perl J, et al. Cerebral embolism associated with left ventricular assist device support and successful therapy with intraarterial urokinase. Ann Thorac Surg. 1999;67:1148-1150.